Robert C. Welsh
Robert C. Welsh
Professor of Medicine, University of Alberta
Verifierad e-postadress på
Citeras av
Citeras av
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction
PW Armstrong, AH Gershlick, P Goldstein, R Wilcox, T Danays, Y Lambert, ...
N Engl J Med 368, 1379-1387, 2013
Randomized trial of primary PCI with or without routine manual thrombectomy
SS Jolly, JA Cairns, S Yusuf, B Meeks, J Pogue, MJ Rokoss, S Kedev, ...
New England Journal of Medicine 372 (15), 1389-1398, 2015
Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial
PW Armstrong, N Bett, D Brieger, D Chew, R Dick, A Farshid, P Garrahy, ...
Journal of the American Medical Association 297 (1), 43-51, 2007
Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction
JA Ezekowitz, P Kaul, JA Bakal, PW Armstrong, RC Welsh, FA McAlister
Journal of the American College of Cardiology 53 (1), 13-20, 2009
Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada
B Elbarouni, SG Goodman, RT Yan, RC Welsh, JM Kornder, JP DeYoung, ...
American heart journal 158 (3), 392-399, 2009
Transcatheter aortic valve implantation: a Canadian Cardiovascular Society position statement
J Webb, J Rodés-Cabau, S Fremes, P Pibarot, M Ruel, R Ibrahim, ...
Canadian Journal of Cardiology 28 (5), 520-528, 2012
Intra‐pulmonary shunt and pulmonary gas exchange during exercise in humans
MK Stickland, RC Welsh, MJ Haykowsky, SR Petersen, WD Anderson, ...
The Journal of physiology 561 (1), 321-329, 2004
Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial …
KR Bainey, SR Mehta, T Lai, RC Welsh
American heart journal 167 (1), 1-14. e2, 2014
Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial
SS Jolly, JA Cairns, S Yusuf, MJ Rokoss, P Gao, B Meeks, S Kedev, ...
The Lancet 387 (10014), 127-135, 2016
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind …
EM Ohman, MT Roe, PG Steg, SK James, TJ Povsic, J White, F Rockhold, ...
The Lancet 389 (10081), 1799-1808, 2017
Does fitness level modulate the cardiovascular hemodynamic response to exercise?
MK Stickland, RC Welsh, SR Petersen, JV Tyberg, WD Anderson, ...
Journal of applied physiology 100 (6), 1895-1901, 2006
Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve: the ARTE (Aspirin Versus …
J Rodés-Cabau, JB Masson, RC Welsh, BG del Blanco, M Pelletier, ...
JACC: Cardiovascular Interventions 10 (13), 1357-1365, 2017
The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines
AD Bell, A Roussin, R Cartier, WS Chan, JD Douketis, A Gupta, ME Kraw, ...
Canadian Journal of Cardiology 27 (3), S1-S59, 2011
The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: a pooled analysis of an early fibrinolytic strategy …
CM Westerhout, E Bonnefoy, RC Welsh, PG Steg, F Boutitie, ...
American heart journal 161 (2), 283-290, 2011
Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study
G Montalescot, B Pitt, E Lopez de Sa, CW Hamm, M Flather, F Verheugt, ...
European heart journal 35 (34), 2295-2302, 2014
Temporal trends in patient and treatment delay among men and women presenting with ST-elevation myocardial infarction
P Kaul, PW Armstrong, S Sookram, BK Leung, N Brass, RC Welsh
American heart journal 161 (1), 91-97, 2011
A Randomized, Double-Blind, Active-Controlled Phase 2 Trial to Evaluate a Novel Selective and Reversible Intravenous and Oral P2Y12 Inhibitor Elinogrel Versus …
RC Welsh, SV Rao, U Zeymer, VP Thompson, K Huber, J Kochman, ...
Circulation: Cardiovascular Interventions 5 (3), 336-346, 2012
Exercise training improves overall physical fitness and quality of life in older women with coronary artery disease
C Hung, B Daub, B Black, R Welsh, A Quinney, M Haykowsky
Chest 126 (4), 1026-1031, 2004
Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y12-receptor inhibitor, versus …
S Leonardi, SV Rao, RA Harrington, DL Bhatt, CM Gibson, MT Roe, ...
American heart journal 160 (1), 65-72, 2010
Trial design: rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: rationale and design of the GALILEO study
S Windecker, J Tijssen, G Giustino, AHC Guimarães, R Mehran, ...
American heart journal 184, 81-87, 2017
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20